Closed Systems Transfer Devices Market worth US$2.09 billion by 2030 with 7.0% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., May 8, 2025 /PRNewswire/ -- The global Closed System Transfer Devices Market, valued at US$1.35 billion in 2024, is forecasted to grow at a robust CAGR of 7.0%, reaching US$1.49 billion in 2025 and an impressive US$2.09 billion by 2030. The closed system transfer devices market has been consistently increasing because of heightened awareness of the risks involved in working with hazardous drugs and the requirement for robust safety protocols within healthcare facilities. The reasons include stringent regulations, heightened concerns about worker safety, and a rise in cancer cases that fuel the use of chemotherapy drugs. In this report, the market is divided into closing mechanism, type, component, technology, end user, and region.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=251802928
Browse in-depth TOC on "Closed Systems Transfer Devices Market"
273 - Tables
65 - Figures
289 - Pages
By Based on type, the closed system transfer devices market is categorized into membrane-to-membrane systems and needleless systems. In 2023, the membrane-to-membrane systems segment held the largest share, by type. The high share and fast growth of this segment are due to their ease of use and lower rate of contamination with double-membrane containment systems. Membrane-to-membrane systems offer higher safety by forming a fully isolated environment during drug transfer.
By technology, the closed system transfer devices market is bifurcated into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. In 2023, the share of the diaphragm-based devices segment was the highest at 43.0%. Diaphragm-based devices tend to be compatible with a wide variety of drug delivery systems and container closures, making them versatile for different clinical uses. They offer flexibility for handling hazardous drugs.
By geography, North America held the largest market share of the closed system transfer devices market in 2024 due to the ongoing research & development of innovative CSTD technologies and better safety, efficiency, and user experience. Additionally, tight regulations over handling hazardous drugs within healthcare environments necessitate the employment of CSTDs to ensure that there is reduced risk exposure to hazardous drugs. Enforcement of these regulations spurs the use of CSTDs within the region.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=251802928
The key players in the global closed system transfer devices market include BD (US), ICU Medical, Inc. (US), EQUASHIELD (US), Corning Incorporated (US), Simplivia Healthcare Ltd. (Israel), JMS (Japan), Baxter (US), Terumo Corporation (Japan), Cardinal Health (US), B Braun Melsungen AG (Germany), West Pharmaceuticals Services, Inc. (US), CODAN Medizinische Geräte GmbH (Germany), Yukon Medical (US), and INSUNG MEDICAL Co., Ltd. (South Korea).
ICU Medical, Inc. (US):
ICU Medical, Inc. has a comprehensive portfolio for the safe handling of dangerous IV medications. Its range of products includes automated and needleless drug compounding systems. The company is engaged in a long-term supply deal with Terumo Corporation (Japan) to distribute its products throughout Japan and Asia, including IV therapy and CSTD products. Over the last three years, the company's infusion consumables segment has grown steadily, taking up the highest share of 37% of the total revenue mix.
BD (US):
BD has a broad product portfolio, including hazardous drug-safe devices such as the PhaSeal and Texium system. It has a global presence spanning more than 50 countries. The BD PhaSeal system works with a wide range of chemotherapeutic medications. It is more widely used in the US and other markets than other CSTDs.
For more information, Inquire Now!
Related Reports:
Respiratory Care Devices Market
Get access to the latest updates on Closed System Transfer Devices Companies and Closed Systems Transfer Devices Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
Share this article